Cukurova University
Adana, Saricam, 01330, Turkey (Türkiye)
NCT Number: NCT07568106
Total knee arthroplasty is associated with moderate to severe postoperative pain, which may delay mobilization and recovery. Multimodal analgesia including regional anesthesia techniques is widely used to improve outcomes. The adductor canal block (ACB) provides anteromedial knee analgesia but may not adequately cover the posterolateral region.
The biceps femoris short head (BiFeS) block is a novel motor-sparing regional anesthesia technique targeting the posterolateral capsule of the knee. This randomized controlled trial aims to compare the analgesic efficacy and functional outcomes of ACB combined with BiFeS block versus ACB alone in patients undergoing total knee arthroplasty.
The primary outcome is posterior knee pain at postoperative 6 hours. Secondary outcomes include pain scores within 48 hours, opioid consumption, early and late functional recovery, and opioid-related adverse effects.
Trial opening soon.
Get Notified18 year–80 year
All sexes
Interventional
Not applicable
Adana, Saricam, 01330, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ultrasound-guided adductor canal block performed with injection of local anesthetic into the adductor canal to block the saphenous nerve and provide postoperative analgesia following total knee arthroplasty.
Ultrasound-guided biceps femoris short head block performed with injection of local anesthetic between the biceps femoris short head and femur to target the posterolateral innervation of the knee for postoperative analgesia.
Sham ultrasound-guided biceps femoris short head block performed with injection of normal saline at the same anatomical location to maintain blinding without providing active analgesia.
Time frame: 6 hours postoperatively
Posterior knee pain assessed using the Numeric Rating Scale (NRS, 0-10), where 0 indicates no pain and 10 indicates worst imaginable pain.
Time frame: 30 minutes, 1, 6, 12, 24, and 48 hours postoperatively
Pain intensity at rest and during movement assessed using the Numeric Rating Scale (NRS, 0-10).
Time frame: 0-48 hours postoperatively
Total opioid consumption measured from patient-controlled analgesia (PCA) device and additional opioid requirements, expressed in milligrams of morphine equivalent.
Time frame: 0-48 hours postoperatively
Requirement for additional analgesic medications (e.g., meperidine, paracetamol, ibuprofen) recorded as yes/no and total doses administered.
Time frame: 24 hours, 48 hours, and 6 weeks postoperatively
Functional recovery assessed by range of motion (ROM), quadriceps muscle strength, time to first ambulation, ability to walk 10 meters without assistance, and performance on the 5-times sit-to-stand test.
Time frame: Preoperatively, 24 hours, 48 hours, and 6 weeks postoperatively
Quadriceps isometric muscle strength measured using a handheld dynamometer and expressed in Nm/kg.
Time frame: Within 48 hours postoperatively
Time from the end of surgery to first successful ambulation, measured in hours.
Time frame: 48 hours postoperatively
Patient satisfaction with postoperative pain management assessed using a 4-point scale (excellent, good, moderate, poor).
Contact information is provided by the study sponsor or research team.
Cukurova University
Other
Effect of Adding a Biceps Femoris Short Head Block to an Adductor Canal Block on Postoperative Pain and Functional Outcomes After Total Knee Arthroplasty: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07506629
Adductor Canal Block, Arthritis
View Trial DetailsNCT07630337
Arthritis, Joint Diseases
Buenos Aires, Argentina
View Trial DetailsNCT07320833
Arthritis, Bites and Stings
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT06083480
Arthritis, Chronic Postsurgical Pain
Nashville, Tennessee, United States
View Trial Details